Phase II study of two dose schedules of C.E.R.A. (Continuous Erythropoietin Receptor Activator) in anemic patients with advanced non-small cell lung cancer (NSCLC) receiving chemot...

por Hirsh, Vera, Glaspy, John, Mainwaring, Paul, Manegold, Christian, Ramlau, Rodryg, Eid, Joseph E
Publicado 2007